Transform drug discovery with predictive human organ models
We are an organ-on-a-chip company that enables you to generate human-specific efficacy and safety data with pioneering PhysioMimix® single- and multi-organ solutions.
Corporate Video
![home | organ-on-a-chip company](https://cn-bio.com/wp-content/uploads/2023/05/home-hero_physioMimix2.png)
Areas to explore
Organ-on-a-chip (OOC) studies are being hailed as the key to faster, more accurate drug discovery. Explore how to harness the power of PhysioMimix® in your own lab or via our contract research services.
![Products icon](https://cn-bio.com/wp-content/uploads/2022/11/icon_products-300x300-1.png)
Products
Learn more about PhysioMimix and why it’s helping drive OOC adoption
![Applications icon](https://cn-bio.com/wp-content/uploads/2022/11/icon_applications-300x300-1.png)
Applications
Explore the varying application areas that PhysioMimix OOC helps support
![icon resource | organ-on-a-chip company](https://cn-bio.com/wp-content/uploads/2023/04/icon_resource.png)
Resources
Dive deeper into our technology through app notes, scientific publications and much more
PhysioMimix®
Organ-on-a-chip
Model human biology in the lab with our microphysiological systems to improve the accuracy and efficiency of drug discovery.
- Delivers human-relevant, translatable data
- Single- and multi-organ capabilities
- Flexible and customisable
- Easy to adopt, simple to use
![PhysioMimix](https://cn-bio.com/wp-content/uploads/2023/05/physiomimix_muli-organ_side-high.png)
What’s new?
Company News
![investment | organ-on-a-chip company](https://cn-bio.com/wp-content/uploads/2024/04/investment.jpg)
CN Bio raises $21 million investment
Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively.
Appnote
![cnb1157 nash appnote tmb v1 | organ-on-a-chip company](https://cn-bio.com/wp-content/uploads/2024/06/cnb1157_nash-appnote_tmb_v1.jpg)
Read our new NASH application note
Developing a translational biomarker panel for use in pre-clinical advanced in vitro studies of Non-alcoholic steatohepatitis
Partnerships
![Inipharm | organ-on-a-chip company](https://cn-bio.com/wp-content/uploads/2023/12/Inipharm.jpg)
PhysioMimix data for Inipharm
PhysioMimix® Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment…
Videos
![cnb769 ht launch homepage tmb v1 | organ-on-a-chip company](https://cn-bio.com/wp-content/uploads/2023/02/cnb769_ht-launch-homepage-tmb_v1.jpg)
Explore PhysioMimix HT
Discover how the next generation of PhysioMimix meets the adoption challenges of OOC…